✦ LIBER ✦

Regulatory Issues in the Use of DNA Vaccines

✍ Scribed by P. D. MINOR

Book ID: 119872520
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 511 KB
Volume: 772
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1995.tb44742.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory issues in the use of insect-c

Regulatory issues in the use of insect-cell culture

✍ Frank L. J. Lier 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 369 KB

The insect cell as host for protein production is relative new. Therefore few data are available. This creates a vicious circle because it makes the choice of insect cells as basis for a pharmaceutical process less attractive. There are three main issues when comparing insect-cells to "traditional"

FDA Perspective on Regulatory Issues in

FDA Perspective on Regulatory Issues in Vaccine Development

✍ BASCOM F. ANTHONY 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Regulatory aspects of allergen vaccines

Regulatory aspects of allergen vaccines in the US

✍ Kristin S. Morrow; Jay E. Slater 📂 Article 📅 2001 🏛 Humana Press Inc 🌐 English ⚖ 92 KB

Advancing TB vaccines to Phase I clinica

Advancing TB vaccines to Phase I clinical trials in the US: regulatory/manufacturing/licensing issues

✍ Sharon S. Rowland; Ronald L. Mayner; Lewellys Barker 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Issues associated with residual cell-sub

Issues associated with residual cell-substrate DNA in viral vaccines

✍ Li Sheng-Fowler; Andrew M. Lewis Jr.; Keith Peden 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The use of recombinant DNA technology in

The use of recombinant DNA technology in the development of fish vaccines

✍ C.B. Munn 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 638 KB